United States · Markets & Finance · Yahoo Finance

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Published by Yahoo Finance · United States 8 h ago

No. 21 / 2026 Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830 ZP9830 is a novel…

Read the full article on Yahoo Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Business Insider

Ukraine is making anti-Shahed missiles that have to cost less than $20,000 per shot

Cointelegraph

Zoom adds ‘proof of human’ badges to show you’re not a deepfake

CNBC

Japanese Prime Minister Takaichi rejects criticism around weak yen and high interest rates

OilPrice.com

Oil Prices Slip as Trump-Putin Diesel Deal Raises Supply Hopes

CoinDesk

Zcash developers plan a fix to keep ZEC swaps private from future quantum computers

Fortune